- Home
- SGN vs TTNP Comparison
SGN vs TTNP Comparison
Compare SGN & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- TTNP
- Stock Information
- Founded
- SGN 2019
- TTNP 1991
- Country
- SGN United States
- TTNP United States
- Employees
- SGN N/A
- TTNP N/A
- Industry
- SGN
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SGN
- TTNP Health Care
- Exchange
- SGN Nasdaq
- TTNP Nasdaq
- Market Cap
- SGN 4.1M
- TTNP 3.7M
- IPO Year
- SGN 2023
- TTNP 1996
- Fundamental
- Price
- SGN $0.18
- TTNP $3.81
- Analyst Decision
- SGN
- TTNP
- Analyst Count
- SGN 0
- TTNP 0
- Target Price
- SGN N/A
- TTNP N/A
- AVG Volume (30 Days)
- SGN 4.9M
- TTNP 8.5K
- Earning Date
- SGN 11-25-2024
- TTNP 11-29-2024
- Dividend Yield
- SGN N/A
- TTNP N/A
- EPS Growth
- SGN N/A
- TTNP N/A
- EPS
- SGN N/A
- TTNP N/A
- Revenue
- SGN $576,488.00
- TTNP $3,000.00
- Revenue This Year
- SGN N/A
- TTNP N/A
- Revenue Next Year
- SGN N/A
- TTNP N/A
- P/E Ratio
- SGN N/A
- TTNP N/A
- Revenue Growth
- SGN 218.74
- TTNP N/A
- 52 Week Low
- SGN $0.11
- TTNP $3.57
- 52 Week High
- SGN $2.70
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SGN 42.04
- TTNP 34.23
- Support Level
- SGN $0.18
- TTNP $3.77
- Resistance Level
- SGN $0.29
- TTNP $4.66
- Average True Range (ATR)
- SGN 0.03
- TTNP 0.28
- MACD
- SGN -0.00
- TTNP 0.04
- Stochastic Oscillator
- SGN 18.66
- TTNP 3.93
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.